Efficacy of balloon occluded/plug assisted retrograde transvenous obliteration (procedure) in liver disease.

Not Applicable

• Conditions: Health Condition 1: K769- Liver disease, unspecified

• Registration Number: CTRI/2023/01/049078
• Lead Sponsor: Institute of Liver and Biliary Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 February 2023

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Age 18-75 years

2.Cirrhotic patients, with GV (GOV2 or IGV1) with eradicated or small low risk esophageal varices with gastrorenal shunt of >10 mm size amenable for BRTO/PARTO.

Exclusion Criteria

1. Non-cirrhotic portal hypertension,

2. History of bleeding from GV

3. Hepatic encephalopathy grade III/IV,

4. Acute kidney injury

5. Patients on beta blocker therapy for > 6 months prior to enrollment in study

6. Hepatocellular carcinoma

7. Portal venous thrombosis

8. Presence of jaundice (bilirubin >3 mg/dl), ascites, Child C, MELD > 18

9. Advanced cardiac or pulmonary diseases

10. Pregnancy

11. Patients not giving informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified